Karamysheva A - Search Results

1

The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.

Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D. Galland F, et al. Among authors: karamysheva a. Oncogene. 1993 May;8(5):1233-40. Oncogene. 1993. PMID: 8386825

2

Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.

Galland F, Karamysheva A, Mattei MG, Rosnet O, Marchetto S, Birnbaum D. Galland F, et al. Among authors: karamysheva a. Genomics. 1992 Jun;13(2):475-8. doi: 10.1016/0888-7543(92)90277-y. Genomics. 1992. PMID: 1319394

3

Expression of the FLT4/VEGFR3 receptor tyrosine kinase encoding gene in hepatic tumors.

Karamysheva A, Shushanov S, Adelaide J, Kakpakova E, Abdryashitov R, Stavrovskaya A, Birnbaum D. Karamysheva A, et al. Int J Oncol. 1996 May;8(5):921-4. doi: 10.3892/ijo.8.5.921. Int J Oncol. 1996. PMID: 21544446

4

VEGFc and VEGFR3 expression in human thyroid pathologies.

Shushanov S, Bronstein M, Adélaïde J, Jussila L, Tchipysheva T, Jacquemier J, Stavrovskaya A, Birnbaum D, Karamysheva A. Shushanov S, et al. Among authors: karamysheva a. Int J Cancer. 2000 Apr 1;86(1):47-52. doi: 10.1002/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r. Int J Cancer. 2000. PMID: 10728593

5

RARα mediates all-trans-retinoic acid-induced VEGF-C, VEGF-D, and VEGFR3 expression in lung cancer cells.

Kalitin NN, Karamysheva AF. Kalitin NN, et al. Among authors: karamysheva af. Cell Biol Int. 2016 Apr;40(4):456-64. doi: 10.1002/cbin.10587. Epub 2016 Feb 10. Cell Biol Int. 2016. PMID: 26818829

6

Expression of vascular endothelial growth factor receptors VEGFR1 in cultured multiple myeloma cells: correlation with immunophenotype and drug resistance.

Kalitin NN, Kostyukova MN, Kakpakova ES, Tupitsyn NN, Karamysheva AF. Kalitin NN, et al. Among authors: karamysheva af. Bull Exp Biol Med. 2012 Oct;153(6):882-5. doi: 10.1007/s10517-012-1850-1. Bull Exp Biol Med. 2012. PMID: 23113309 English, Russian.

7

[Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma].

Golenkov AK, Buravtsova IV, Dudina GA, Lutskaia TD, Mitina TA, Kataeva EV, Karamysheva AF, Kakpakova ES, Sablina IuA, Stavrovskaia AA. Golenkov AK, et al. Among authors: karamysheva af. Ter Arkh. 2013;85(7):98-102. Ter Arkh. 2013. PMID: 24137956 Russian.

8

Mechanisms of angiogenesis.

Karamysheva AF. Karamysheva AF. Biochemistry (Mosc). 2008 Jul;73(7):751-62. doi: 10.1134/s0006297908070031. Biochemistry (Mosc). 2008. PMID: 18707583 Free article. Review.

9

[Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome].

Kalitin NN, Dudina GA, Semochkin SV, Karamysheva AF. Kalitin NN, et al. Among authors: karamysheva af. Ter Arkh. 2017;89(7):39-44. doi: 10.17116/terarkh201789739-44. Ter Arkh. 2017. PMID: 28766539 Russian.

10

Vascular endothelial growth factor receptor 3 is a novel marker differing CD138-positive and CD138-negative multiple myeloma cells.

Kostjukova MN, Tupitsyn NN, Karamysheva AF. Kostjukova MN, et al. Among authors: karamysheva af. Br J Haematol. 2018 Jun;181(6):840-843. doi: 10.1111/bjh.14706. Epub 2017 May 16. Br J Haematol. 2018. PMID: 28508400 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters